397.50p+10.00 (+2.58%)04 Jul 2022, 16:17
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.

Maxcyte INC Market & Company News

01.07.2022 07:00MXCTTotal Voting RightsRNS
30.06.2022 07:00MXCTResult of AGMRNS
22.06.2022 15:48ZAIM, XPF, TRINUK shareholder meetings calendar - next 7 daysAlliance
17.06.2022 14:51MXCTHoldings in CompanyRNS
06.06.2022 07:00MXCTPublication of Annual ReportRNS
27.05.2022 07:00MXCTNotice of AGMRNS
16.05.2022 07:00MXCTInducement GrantsRNS
10.05.2022 12:01MXCTIN BRIEF: MaxCyte first-quarter loss narrows; raises annual guidanceAlliance
10.05.2022 07:00MXCTFiling of Form 10-QRNS
10.05.2022 07:00MXCTMaxCyte Reports First Quarter Financial ResultsRNS
04.05.2022 07:00MXCTUpcoming Investor ConferencesReach
29.04.2022 14:41MXCTTotal Voting RightsRNS
19.04.2022 07:00MXCTInducement Grants Under Nasdaq Listing Rule 5635RNS
13.04.2022 18:47DIS, PRTC, MXCTTRADING UPDATES: BlueRock output rises; Watkin Jones profit to fallAlliance
13.04.2022 07:00MXCTDeparture of CFO and Preliminary Q1 2022 RevenueRNS
11.04.2022 07:00MXCTHolding(s) in CompanyRNS
01.04.2022 07:02MXCTTotal Voting RightsRNS
28.03.2022 13:19MXCTGrant of Options and PDMR DealingRNS
28.03.2022 07:00MXCTGrant of Options and PDMR DealingRNS
23.03.2022 17:22MXCTMaxCyte widens net loss in 2021 while annual revenue increasesAlliance
23.03.2022 07:00MXCTFourth Quarter and Full Year Financial ResultsRNS
15.03.2022 15:52ZTF, YOU, TRSTUK earnings, trading statements calendar - next 7 daysAlliance
10.03.2022 15:57MXCTIN BRIEF: MaxCyte hires chief scientist from Stemson TherapeuticsAlliance
10.03.2022 07:00MXCTMaxCyte, Names Cenk Sumen Chief Scientific OfficerRNS
08.03.2022 14:29MXCTHolding(s) in CompanyRNS
03.03.2022 09:45MXCTHolding(s) in CompanyRNS
01.03.2022 07:00MXCTBlock Listing ReturnRNS
24.02.2022 13:00MXCTNotice of ResultsRNS
22.02.2022 15:56MXCTHolding(s) in CompanyRNS
21.02.2022 07:00MXCTConsolidation of Trading LinesRNS
14.02.2022 13:00MXCTUpcoming Investor ConferencesRNS
14.02.2022 07:00MXCTInducement Grants Under Nasdaq Listing RuleRNS
01.02.2022 07:00MXCTLicense with Intima BioscienceRNS
24.01.2022 07:30MXCTPreliminary Unaudited Q4 & FY 2021 Revenue ResultsRNS
29.12.2021 15:30MXCTHoldings in CompanyRNS
01.12.2021 17:00MXCTTotal Voting RightsRNS
23.11.2021 07:32MXCTPurchase of Common StockRNS
17.11.2021 17:36MXCTExercise of options and PDMR DealingRNS
11.11.2021 07:00MXCTMaxCyte Reports Third Quarter Financial ResultsRNS
03.11.2021 13:00MXCTAppointment of Chairman of the BoardRNS
29.10.2021 17:01MXCTResult of AGMRNS
28.10.2021 15:00MXCTLicense with Nkarta, Inc.RNS
26.10.2021 07:00MXCTNotice of ResultsRNS
06.10.2021 07:00MXCTHoldings in CompanyRNS
01.10.2021 15:49MXCTNotice of AGM and Change of DirectorRNS
01.10.2021 12:36MXCTTotal Voting RightsRNS
17.09.2021 14:35MXCTMaxCyte Set to Join Russell 2000® IndexReach
14.09.2021 07:00MXCTHalf-year ReportRNS
14.09.2021 07:00MXCTFiling of Form 10-QRNS
06.09.2021 17:21MXCTIssue of Equity and Total Voting RightsRNS
02.09.2021 14:26MXCTNotice of ResultsRNS
10.08.2021 07:00MXCTGrant of OptionsRNS
09.08.2021 07:00MXCTLicense with Sana BiotechnologyRNS
05.08.2021 16:05MXCTAmendments to BylawsRNS
03.08.2021 15:51MXCTClosing of OfferingRNS
02.08.2021 07:00MXCTFull Exercise of Over-Allotment OptionRNS
30.07.2021 16:43MXCTSecond Price Monitoring ExtnRNS
30.07.2021 16:36MXCTPrice Monitoring ExtensionRNS
30.07.2021 07:00MXCTPricing of Offering and Approval to List on NasdaqRNS
26.07.2021 11:14MXCTLaunch of Offering and Application to ListRNS
19.07.2021 12:30MXCTTermination of DI facility and transition to CDIRNS
12.07.2021 07:00MXCTS-1 Financial information & Directorate ChangeRNS
12.07.2021 07:00MXCTPublic Filing of Registration Statement with SECRNS
06.07.2021 17:36MXCTResult of Special MeetingRNS
16.06.2021 07:01MXCTPublication of Annual Report and AccountsRNS
16.06.2021 07:00MXCTStockholder Circular and Notice of Special MeetingRNS
15.06.2021 07:00MXCTMaxcyte Appoints Two New Non-Executive DirectorsRNS
02.06.2021 09:18MXCTTotal Voting RightsRNS
25.05.2021 07:00MXCTSigning of Strategic Platform LicenceRNS
14.05.2021 07:00MXCTProposed Dual-Listing on NasdaqRNS
13.05.2021 07:00MXCTConsolidation of Trading LinesRNS
20.04.2021 07:00MXCTFull Year ResultsRNS
15.04.2021 07:00MXCTNotice of Full Year ResultsRNS
01.04.2021 07:00MXCTTotal Voting RightsRNS
11.03.2021 15:01MXCTHolding(s) in CompanyRNS
Showing 1 to 75 of 90